Penny Anders Email & Phone Number

Chapel Hill, NC, US

Durham, North Carolina, United States

• Identified, procured and managed the installation of laboratory equipment and reagents for a new laboratory. The lab is now fully operational.
• Standardizes and characterizes full spectrum flow cytometers to align with cytometers at other locations.
• Interfaces with employees within finance, procurement, warehouse, and facilities to make new lab operational.
• Team lead for the development and optimization of two full spectrum flow cytometer assays.
• Writes SOPs.
• Trains and supervises junior and senior scientists.

Durham, North Carolina, United States

• Developing flow cytometry-based assays to evaluate first-in-human therapeutic drug candidates.
• Writing and editing qualification and validation plans and worksheets.
• Validating GLP and GCLP-compliant flow cytometry-based assays.
• Performing multi-color flow cytometry to evaluate cellular responses to therapeutic drug candidates.

Chapel Hill, NC 27510

• Investigating the efficacy of new immune therapeutic drug candidates to relieve immune suppression and to treat lung and bladder cancers.
• Designing and optimizing flow cytometry antibody panels to compare immune subsets in lung and bladder cancer models before and after treatment.
• Trained new postdoctoral research fellows on utilizing techniques such as multi-color flow cytometry and immunohistochemistry.
• Developed a novel transgenic mouse model in which transgenic mice develop B cell lymphomas. The model can now be used to understand KSHV pathology and to identify therapeutic candidates (Anders et al., JCI, 2018).

Chapel Hill, NC

• Managed three oncology-related research projects from inception to completion. Generated three first author publications (Anders et al., JCI, 2018, PLoS Pathog, 2016, and Leuk Lymphoma, 2015).
• Extensively evaluated therapeutic drug candidates that target Non-Hodgkin Lymphoma.
• Presented scientific research results via posters and oral presentations at the International Herpesvirus Conferences (Ghent, Belgium 2017, Madison, USA 2016, and Puerto Vallarta, Mexico 2013).
• Supervised a graduate student during the planning and testing of drugs for the pharmaceutical company ArQule.
• Generated cDNA library that was sequenced on an Illumina MiSeq (Anders et al., JCI, 2018).

Seattle, WA

• Designed and executed experiments aimed at evaluating monoclonal antibody therapies in murine models of allergic airway inflammation.
• Created and optimized phospho-protein assays to evaluate on target efficacy of first-in-human drug candidates by multi-color flow cytometry.
• Compared inhibitory dose responses of drug candidates in human whole blood by multi-color flow cytometry.
• Identified and implemented the gold standard for evaluating in vivo respiratory mechanics (flexiVent).
• Collaborated with an academic scientist to learn and implement the technique. Trained colleagues (Rickel et al., J Immunol, 2008).

Microbiology And Immunology, Laboratory Of Dr. Blossom Damania

Chemistry

completed advanced courses in Chemistry

Ann Arbor Program Abroad, Florence, Italy

B.S., Anthropology